NASDAQ:CYAD
$0.470
(
0%
)
Friday, 26th May 2023
Celyad SA Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.470 | $0.760 | Friday, 26th May 2023 CYAD stock ended at $0.470. During the day the stock fluctuated 0% from a day low at $0.470 to a day high of $0.470. |
| 90 days | $0.470 | $1.18 | |
| 52 weeks | $0.460 | $3.07 |
Historical Celyad SA prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $0.470 | $0.470 | $0.470 | $0.470 | 0 |
| 2023-05-25 | $0.470 | $0.470 | $0.470 | $0.470 | 0 |
| 2023-05-24 | $0.470 | $0.470 | $0.470 | $0.470 | 0 |
| 2023-05-23 | $0.470 | $0.470 | $0.470 | $0.470 | 0 |
| 2023-05-22 | $0.470 | $0.470 | $0.470 | $0.470 | 0 |
| 2023-05-19 | $0.470 | $0.470 | $0.470 | $0.470 | 0 |
| 2023-05-18 | $0.520 | $0.528 | $0.470 | $0.470 | 48 998 |
| 2023-05-17 | $0.550 | $0.540 | $0.529 | $0.529 | 9 401 |
| 2023-05-16 | $0.573 | $0.589 | $0.535 | $0.556 | 28 351 |
| 2023-05-15 | $0.560 | $0.635 | $0.520 | $0.635 | 14 653 |
| 2023-05-12 | $0.589 | $0.650 | $0.572 | $0.590 | 7 544 |
| 2023-05-11 | $0.580 | $0.650 | $0.530 | $0.615 | 16 910 |
| 2023-05-10 | $0.594 | $0.594 | $0.550 | $0.580 | 9 304 |
| 2023-05-09 | $0.570 | $0.590 | $0.560 | $0.570 | 23 031 |
| 2023-05-08 | $0.610 | $0.639 | $0.535 | $0.550 | 53 588 |
| 2023-05-05 | $0.580 | $0.700 | $0.580 | $0.619 | 43 749 |
| 2023-05-04 | $0.630 | $0.680 | $0.600 | $0.680 | 18 473 |
| 2023-05-03 | $0.580 | $0.690 | $0.580 | $0.630 | 4 568 |
| 2023-05-02 | $0.670 | $0.625 | $0.600 | $0.600 | 3 174 |
| 2023-05-01 | $0.690 | $0.700 | $0.612 | $0.670 | 6 392 |
| 2023-04-28 | $0.670 | $0.760 | $0.660 | $0.720 | 4 463 |
| 2023-04-27 | $0.675 | $0.720 | $0.670 | $0.720 | 9 491 |
| 2023-04-26 | $0.662 | $0.705 | $0.660 | $0.688 | 5 181 |
| 2023-04-25 | $0.670 | $0.712 | $0.670 | $0.712 | 7 414 |
| 2023-04-24 | $0.763 | $0.763 | $0.650 | $0.707 | 14 016 |
| 2023-04-21 | $0.600 | $0.700 | $0.580 | $0.640 | 8 565 |
| 2023-04-20 | $0.776 | $0.776 | $0.630 | $0.646 | 50 715 |
| 2023-04-19 | $0.80 | $0.82 | $0.600 | $0.630 | 68 333 |
| 2023-04-18 | $0.82 | $0.89 | $0.80 | $0.80 | 7 126 |
| 2023-04-17 | $0.82 | $0.88 | $0.80 | $0.84 | 4 727 |
| 2023-04-14 | $0.84 | $0.85 | $0.83 | $0.83 | 6 712 |
| 2023-04-13 | $0.89 | $0.89 | $0.83 | $0.83 | 8 693 |
| 2023-04-12 | $0.93 | $0.96 | $0.87 | $0.96 | 5 750 |
| 2023-04-11 | $0.86 | $0.96 | $0.85 | $0.94 | 5 025 |
| 2023-04-10 | $0.83 | $0.83 | $0.770 | $0.81 | 8 467 |
| 2023-04-06 | $0.89 | $0.89 | $0.86 | $0.86 | 2 877 |
| 2023-04-05 | $0.84 | $0.86 | $0.84 | $0.86 | 6 548 |
| 2023-04-04 | $0.93 | $0.94 | $0.87 | $0.92 | 7 883 |
| 2023-04-03 | $0.87 | $0.93 | $0.87 | $0.93 | 1 984 |
| 2023-03-31 | $0.86 | $0.96 | $0.86 | $0.96 | 5 061 |
| 2023-03-30 | $0.86 | $0.94 | $0.86 | $0.93 | 7 853 |
| 2023-03-29 | $0.88 | $0.94 | $0.85 | $0.90 | 12 233 |
| 2023-03-28 | $0.87 | $0.90 | $0.87 | $0.88 | 1 932 |
| 2023-03-27 | $0.88 | $0.93 | $0.83 | $0.83 | 6 587 |
| 2023-03-24 | $0.83 | $0.96 | $0.83 | $0.88 | 4 146 |
| 2023-03-23 | $0.90 | $0.90 | $0.81 | $0.87 | 10 660 |
| 2023-03-22 | $0.87 | $0.96 | $0.80 | $0.89 | 10 866 |
| 2023-03-21 | $0.81 | $0.96 | $0.81 | $0.86 | 7 795 |
| 2023-03-20 | $0.88 | $0.95 | $0.81 | $0.86 | 16 353 |
| 2023-03-17 | $0.89 | $0.94 | $0.700 | $0.85 | 16 316 |
About Celyad SA
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
